Research Solutions (NASDAQ:RSSS – Get Free Report) is expected to post its Q4 2025 results after the market closes on Thursday, September 18th. Analysts expect Research Solutions to post earnings of $0.03 per share and revenue of $12.5090 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earningreport page for the latest details on the call scheduled for Thursday, September 18, 2025 at 5:00 PM ET.
Research Solutions Trading Up 3.4%
Shares of Research Solutions stock opened at $3.33 on Thursday. The company has a market cap of $108.09 million, a price-to-earnings ratio of -23.78, a PEG ratio of 3.58 and a beta of 0.66. Research Solutions has a 1 year low of $2.32 and a 1 year high of $4.24. The company’s fifty day simple moving average is $2.89 and its 200-day simple moving average is $2.82.
Institutional Trading of Research Solutions
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RSSS. Topline Capital Management LLC acquired a new position in shares of Research Solutions during the 2nd quarter worth about $125,000. Acadian Asset Management LLC lifted its holdings in shares of Research Solutions by 83.7% during the 1st quarter. Acadian Asset Management LLC now owns 87,327 shares of the company’s stock valued at $225,000 after purchasing an additional 39,789 shares in the last quarter. Finally, NewEdge Advisors LLC acquired a new position in Research Solutions during the 1st quarter worth approximately $71,000. 33.60% of the stock is currently owned by institutional investors and hedge funds.
Research Solutions Company Profile
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets.
Further Reading
- Five stocks we like better than Research Solutions
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion
- Consumer Discretionary Stocks Explained
- Despite Pullback, Rocket Lab Still Looks Primed for a Breakout
- What is the S&P/TSX Index?
- Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.